Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ITIL-306 |
Synonyms | |
Therapy Description |
ITIL-306 comprises autologous tumor infiltrating lymphocytes engineered to express a costimulatory antigen receptor targeting FOLR1 as well as the CD28 and CD40 costimulatory domains, which potentially induce killing of FOLR1-expressing tumor cells and enhance antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10, NCI Drug Dictionary). |